Role of bacteria in chronic prostatitis/ chronic pelvic pain syndrome

Current Urology Reports

Volumn 6, Issue 4, 2005, Pages 300-306

  Hua, Vi N ^b   Williams, Daniel H ^b   Schaeffer, Anthony J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NONE

Author keywords

Chronic Pelvic Pain Syndrome; Chronic Prostatitis; Normal Prostate; Pelvic Pain Syndrome; Prostatitis

Indexed keywords

CYTOKINE;

ANIMAL; BIOFILM; CHRONIC DISEASE; CLASSIFICATION; HUMAN; IMMUNOLOGY; MALE; MICROBIOLOGY; PELVIS PAIN SYNDROME; PHYSIOLOGY; PROSTATE; PROSTATITIS; REVIEW; SYNDROME;

ANIMALS; BIOFILMS; CHRONIC DISEASE; CYTOKINES; HUMANS; MALE; PELVIC PAIN; PROSTATE; PROSTATITIS; SYNDROME;

EID: 27744455234     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-005-0028-z     Document Type: Article

References (36)

1. Krieger JN, Ross SO, Riley DE: Chronic prostatitis: epidemiology and role of infection. Urology 2002, 60(suppl):8–13. DOI: 10.1016/S0090-4295(02)02294-X
2. Roberts RO, Lieber MM, Rhodes T, et al.: Prevalence of a physician-assigned diagnosis of prostatitis: the Olmsted County Study of Urinary Symptoms and Health Status Among Men. Urology 1998, 51:578–584. DOI: 10.1016/S0090-4295(98)00034-X
3. Krieger JN, Egan KJ: Comprehensive evaluation and treatment of 75 men referred to chronic prostatitis clinic. Urology 1991, 38:11–19. DOI: 10.1016/0090-4295(91)80004-Q
4. Drach GW, Fair WR, Meares EM, Stamey TA: Classification of benign diseases associated with prostatic pain: Prostatitis or prostatodynia? J Urol 1978, 120:266.
5. Meares EM, Stamey TA: Bacteriologic localization patterns in bacterial prostatitis and urethritis. Invest Urol 1968, 5:492–518.
6. Krieger JN, Nyberg L Jr, Nickel JC: NIH consensus definition and classification of prostatitis. JAMA 1999, 282:236–237. DOI: 10.1001/jama.282.3.236
7. Litwin MS, McNaughton-Collins M, Fowler FJ Jr, et al.: The National Institutes of Health Chronic Prostatitis Symptom Index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network. J Urol 1999, 162:369–375. DOI: 10.1016/S0022-5347(05)68562-X
8. Schaeffer AJ, Wendel EF, Dunn JK, Grayhack JT: Prevalence and significance of prostatic inflammation. J Urol 1981, 125:215–219.
9. Hochreiter WW, Duncan JL, Schaeffer AJ: Evaluation of the bacterial flora of the prostate using a 16S rRNA gene-based polymerase chain reaction. J Urol 2000, 163:127–130. This reference details expected flora in the normal prostate. DOI: 10.1016/S0022-5347(05)67987-6
10. Nickel JC, Alexander RB, Schaeffer AJ, et al.: Leukocytes and bacteria in men with chronic prostatitis/chronic pelvic pain syndrome compared to asymptomatic controls. J Urol 2003, 170:818–822. DOI: 10.1097/01.ju.0000082252.49374.e9
11. Schaeffer AJ, Knauss JS, Landis JR, et al.: Leukocyte and bacterial counts do not correlate with severity of symptoms in men with chronic prostatitis: the National Institutes of Health Chronic Prostatitis Cohort Study. J Urol 2002, 168:1048–1053. DOI: 10.1016/S0022-5347(05)64572-7
12. Lee JC, Muller CH, Rothman I, et al.: Prostate biopsy culture findings of men with chronic pelvic pain syndrome do not differ from those of healthy controls. J Urol 2003, 169:584–588. DOI: 10.1016/S0022-5347(05)63958-4
13. Krieger JN, Riley DE: Bacteria in the chronic prostatitischronic pelvic pain syndrome: molecular approaches to critical research questions. J Urol 2002, 167:2574–2583. DOI: 10.1016/S0022-5347(05)65041-0
14. Josephson KL, Gerba CP, Pepper IL: Polymerase chain reaction detection of nonviable bacterial pathogens. Appl Environ Microbiol 1993, 59:3513–3515.
15. Vranes J, Kruzic V, Sterk-Kuzmanovic N, Schonwald S: Virulence characteristics of Escherichia coli strains causing asymptomatic bacteriuria. Infection 2003, 31:216–220.
16. Johnson JR: Microbial virulence determinants and the pathogenesis of urinary tract infection. Infect Dis Clin North Am 2003, 17:261–278. DOI: 10.1016/S0891-5520(03)00027-8
17. Blomgran R, Zheng L, Stendahl O: Uropathogenic Escherichia coli triggers oxygen-dependent apoptosis in human neutrophils through the cooperative effect of type-1 fimbriae and lipopolysaccharide. Infect Immun 2004, 72:4570–4578. DOI: 10.1128/IAI.72.8.4570-4578.2004
18. Kanamaru S, Kurazono H, Ishitoya S, et al.: Distribution and genetic association of putative uropathogenic virulence factors iroN, iha, kpsMT, ompT and usp in Escherichia coli isolated from urinary tract infections in Japan. J Urol 2003, 170:2490–2493. DOI: 10.1097/01.ju.0000094185.48467.dc
19. Nickel JC, Olson ME, Barabas A, et al.: Pathogenesis of chronic bacterial prostatitis in an animal model. Br J Urol 1990, 66:47–54. DOI: 10.1111/j.1464-410X.1990.tb14864.x
20. Costerton JW, Stewart PS, Greenberg EP: Bacterial biofilms: a common cause of persistent infections. Science 1999, 284:1318–1322. This reference details new avenues of research into bacterial biofilms. DOI: 10.1126/science.284.5418.1318
21. Stewart PS, Costerton JW: Antibiotic resistance of bacteria in biofilms. Lancet 2001, 358:135–138. DOI: 10.1016/S0140-6736(01)05321-1
22. Krieger JN, Jacobs RR, Ross SO: Does the chronic prostatitis/ pelvic pain syndrome differ from nonbacterial prostatitis and prostatodynia? J Urol 2000, 164:1554–1558. DOI: 10.1016/S0022-5347(05)67027-9
23. True LD, Berger RE, Rothman I, et al.: Prostate histopathology and the chronic prostatitis/chronic pelvic pain syndrome: a prospective biopsy study. J Urol 1999, 162:2014–2018. DOI: 10.1016/S0022-5347(05)68090-1
24. Hochreiter WW, Nadler RB, Koch AE, et al.: Evaluation of the cytokines interleukin 8 and epithelial neutrophil activating peptide 78 as indicators of inflammation in prostatic secretions. Urology 2000, 56:1025–1029. DOI: 10.1016/S0090-4295(00)00844-X
25. Nadler RB, Koch AE, Calhoun EA, et al.: IL-1beta and TNFalpha in prostatic secretions are indicators in the evaluation of men with chronic prostatitis. J Urol 2000, 164:214–218. DOI: 10.1016/S0022-5347(05)67497-6
26. Pontari MA, Ruggieri MR: Mechanisms in prostatitis/chronic pelvic pain syndrome. J Urol 2004, 172:839–845. DOI: 10.1097/01.ju.0000136002.76898.04
27. John H, Barghorn A, Funke G, et al.: Noninflammatory chronic pelvic pain syndrome: immunological study in blood, ejaculate, and prostate tissue. Eur Urol 2001, 39:72–78. DOI: 10.1159/000052415
28. Anderson GG, Palermo JJ, Schilling JD, et al.: Intracellular bacterial biofilm-like pods in urinary tract infections. Science 2003, 301:105–107. DOI: 10.1126/science.1084550
29. Schaeffer AJ, Landis JR, Knauss JS, et al.: Demographic and clinical characteristics of men with chronic prostatitis: the National Institutes of Health Chronic Prostatitis Cohort Study. J Urol 2002, 168:593–598. This reference details the characteristics of men with CP/CPPS syndrome. DOI: 10.1016/S0022-5347(05)64686-1
30. Nickel JC, Downey J, Johnston B, et al.: Predictors of patient response to antibiotic therapy for the chronic prostatitis/ chronic pelvic pain syndrome: a prospective multicenter clinical trial. J Urol 2001, 165:1539–1544. DOI: 10.1016/S0022-5347(05)66344-6
31. Turner JA, Ciol MA, Von Korff M, Berger R: Prognosis of patients with new prostatitis/pelvic pain syndrome episodes. J Urol 2004, 172:538–541. DOI: 10.1097/01.ju.0000132797.63480.44
32. Nickel JC, Downey J, Ardern D, et al.: Failure of a monotherapy strategy for difficult chronic prostatitis/chronic pelvic pain syndrome. J Urol 2004, 172:551–554. DOI: 10.1097/01.ju.0000131592.98562.16
33. Shoskes DA, Hakim L, Ghoniem G, Jackson CL: Long-term results of multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome. J Urol 2003, 169:1406–1410. DOI: 10.1097/01.ju.0000055549.95490.3c
34. Yoshimura T, Kurita C, Usami E, et al.: Immunomodulatory action of levofloxacin on cytokine production by human peripheral blood mononuclear cells. Chemotherapy 1996, 42:459–464.
35. Galley HF, Dhillon JK, Paterson RL, Webster NR: Effect of ciprofloxacin on the activation of the transcription factors nuclear factor kappaB, activator protein-1 and nuclear factorinterleukin-6, and interleukin-6 and interleukin-8 mRNA expression in a human endothelial cell line. Clin Sci (Lond) 2000, 99:405–410. DOI: 10.1042/CS20000073
36. Schaeffer AJ, Datta NS, Fowler JE Jr, et al.: Overview summary statement. Diagnosis and management of chronic prostatitis/ chronic pelvic pain syndrome (CP/CPPS). Urology 2002, 60(suppl):1–4. DOI: 10.1016/S0090-4295(02)01979-9